Integrated autolysis, DNA hydrolysis and precipitation enables an improved bioprocess for Q-Griffithsin, a broad-spectrum antiviral and clinical-stage anti-COVID-19 candidate

Across the biomanufacturing industry, innovations are needed to improve efficiency and flexibility, especially in the face of challenges such as the COVID-19 pandemic. Here we report an improved bioprocess for Q-Griffithsin, a broad-spectrum antiviral currently in clinical trials for COVID-19. Q-Gri...

Descripción completa

Detalles Bibliográficos
Autores principales: Decker, John S., Menacho-Melgar, Romel, Lynch, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917701/
https://www.ncbi.nlm.nih.gov/pubmed/35308834
http://dx.doi.org/10.1016/j.bej.2022.108403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917701/
https://www.ncbi.nlm.nih.gov/pubmed/35308834
http://dx.doi.org/10.1016/j.bej.2022.108403

Ejemplares similares